TABLE-LTT Bio-Pharma <4566.T>-1qtr group results

Thu Jul 30, 2009 9:30pm EDT 

   July 31 (Reuters) -
                LTT BIO-PHARMA CO. LTD.
                CONSOLIDATED FINANCIAL HIGHLIGHTS
 (in billions of yen unless specified)
             3 months ended  3 months ended    6 months to     Year to   
               Jun 30, 2009    Jun 30, 2008    Sep 30, 2009    Mar 31, 2010
               LATEST          YEAR-AGO        H1              LATEST    
               RESULTS         RESULTS         FORECAST        FORECAST  
 Sales                  6 mln         299 mln          52 mln         150 mln
                (-97.9 pct)                                              
 Operating        loss 91 mln    loss 279 mln    loss 238 mln    loss 401 mln
 Recurring        loss 90 mln    loss 170 mln    prft 164 mln      prft 3 mln
 Net              loss 80 mln     prft 47 mln    prft 173 mln     prft 12 mln
 EPS             loss Y611.21    prft Y363.96  prft Y1,317.43     prft Y95.42
  EPS                                 Y361.35                               
 NOTE - LTT Bio-Pharma Co. Ltd. researches and develops medicines.
 For latest earnings estimates made by Toyo Keizai, please
double click on 4566.TK1.
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.